AR106442A1 - ANTI-IL2 ANTIBODIES, COMPOSITIONS AND USES - Google Patents
ANTI-IL2 ANTIBODIES, COMPOSITIONS AND USESInfo
- Publication number
- AR106442A1 AR106442A1 ARP160103221A ARP160103221A AR106442A1 AR 106442 A1 AR106442 A1 AR 106442A1 AR P160103221 A ARP160103221 A AR P160103221A AR P160103221 A ARP160103221 A AR P160103221A AR 106442 A1 AR106442 A1 AR 106442A1
- Authority
- AR
- Argentina
- Prior art keywords
- antibodies
- provides
- compositions
- immunosuppression
- encode
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente proporciona anticuerpos o sus porciones de unión a antígeno, los cuales se unen específicamente a IL 2 y reducen la afinidad de unión de IL 2 a IL 2Ra e IL 2Rb. Proporciona además un método para obtener dichos anticuerpos y los ácidos nucleicos que los codifican. Se relaciona además con composiciones y métodos terapéuticos para usar estos anticuerpos para el tratamiento y/o prevención de enfermedades, trastornos o condiciones autoinmunes y para inmunosupresión, incluyendo no taxativamente, la administración de un complejo que comprende el anticuerpo e IL 2. Vector. Célula.This provides antibodies or their antigen binding portions, which specifically bind to IL 2 and reduce the binding affinity of IL 2 to IL 2Ra and IL 2Rb. It also provides a method to obtain said antibodies and the nucleic acids that encode them. It also relates to therapeutic compositions and methods for using these antibodies for the treatment and / or prevention of autoimmune diseases, disorders or conditions and for immunosuppression, including but not limited to, the administration of a complex comprising the antibody and IL 2. Vector. Cell.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562245600P | 2015-10-23 | 2015-10-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR106442A1 true AR106442A1 (en) | 2018-01-17 |
Family
ID=61159867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160103221A AR106442A1 (en) | 2015-10-23 | 2016-10-21 | ANTI-IL2 ANTIBODIES, COMPOSITIONS AND USES |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR106442A1 (en) |
-
2016
- 2016-10-21 AR ARP160103221A patent/AR106442A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019002566A1 (en) | Anti-phf-tau antibodies and their uses. | |
| CL2020003028A1 (en) | Anti-cd33 antibodies, anti-cd33 / anti-cd3 bispecific antibodies and their uses. | |
| CO2018012415A2 (en) | Specific binding proteins and uses thereof | |
| AR109276A1 (en) | ANTI-hCTLA 4 ANTIBODIES | |
| CL2020001854A1 (en) | Gprc5d binding antibodies. | |
| EA201992131A1 (en) | HIGH-AFFINE SPECIFIC TO MAGE-A1 TCR AND THEIR APPLICATION | |
| AR105444A1 (en) | THERAPEUTIC ANTIBODIES THAT JOIN THE PROTEIN CODIFIED BY THE GENOPHYPE ACTIVATION GEN 3 (LAG3) | |
| MX2021011697A (en) | Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123. | |
| UY36687A (en) | ANTIBODIES AGAINST OX40 AND ITS USES | |
| PE20210488A1 (en) | ANTIBODIES SPECIFIC TO GUCY2C AND ITS USES | |
| CR20170079A (en) | UNION AGENTS TO CD123 AND USES OF THESE | |
| ECSP19011185A (en) | Bispecific antibody-like binding proteins that specifically bind CD3 and CD123 | |
| EA201891732A1 (en) | BISPECIFIC BINDING PROTEINS FOR PD-L1 AND KDR | |
| BR112017006468A2 (en) | bispecific antibody, pharmaceutical composition, kit, use of a combination of a bispecific antibody and cancer treatment method | |
| PE20210708A1 (en) | ANTIBODIES SPECIFIC TO CD70 AND THEIR USES | |
| CL2021000909A1 (en) | Stabilizing Trem2 Antibodies | |
| CL2020001334A1 (en) | Antibodies that bind to the envelope protein of the Zika virus and their uses. (divisional request 201900999) | |
| CL2020001629A1 (en) | Hla-a2 / wt1 binding antibodies. | |
| MX2020009130A (en) | Therapeutic anti-spla2-gib antibodies and the uses thereof. | |
| AR108975A1 (en) | ANTIBODIES WITH LOW IMMUNOGENICITY AND ITS USES | |
| CO2019010164A2 (en) | Antibodies that bind steap-1 | |
| AR106442A1 (en) | ANTI-IL2 ANTIBODIES, COMPOSITIONS AND USES | |
| UY38432A (en) | MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO CD20 ANTIGEN | |
| MX2020004026A (en) | Monoclonal antibody to il-5r¿. | |
| AR117579A1 (en) | SPECIFIC ANTIBODIES FOR GUCY2C AND ITS USES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |